ArticleIn vivo (Athens, Greece)

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance.

Pietro Pepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.